Rib-X Pharmaceuticals Inc. Garners $25,000,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=67a665de-f29d-4130-8d63-cc7dc216d0e7&Preview=1 -
Date
1/26/2009 -
Company Name
Rib-X Pharmaceuticals Inc. -
Mailing Address
300 George Street New Haven, CT 06511-6663 -
Company Description
Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the 50S subunit of the ribosome, which performs an essential role in the fundamental process of protein synthesis. -
Website
http://www.rib-x.com -
Transaction Type
Debt -
Transaction Amount
$25,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Warburg Pincus -
Venture Investor
ABS Ventures -
Venture Investor
Axiom Venture Partners -
Venture Investor
EuclidSR Partners -
Venture Investor
MedImmune Ventures -
Venture Investor
Oxford Bioscience Partners -
Venture Investor
SR One -
Venture Investor
Undisclosed
